Industry insights and honest opinions

From our clients and partners

Gina Lee
30 May 2022

Alfred Romann
16 February 2022
China Daily

Zhang Mengying
28 March 2022
BioWorld Medtech

Bahati News and Views

Uruguay in unique position: A trade surplus with China

Uruguay, one of the most stable economies in Latin America, is increasingly looking to China to boost trade and growth.
Read More →

Car sales offer a microcosm of China’s economy

China’s auto market offers a great case study for much of what is happening with China’s economy. Like much of China’s broader economy, the market ...
Read More →

Cryptocurrencies interesting but too small to move mountains

Cryptocurrencies continue to fuel debate among regulators and users.
Read More →

A long-awaited emotional and financial boost for China’s cancer patients

Imagine this: if your beloved one was diagnosed of a fatal cancer, dealing with heartbreaks aside, you had to start borrowing money for the treatment. ...
Read More →

Tariffs Notwithstanding, Globalization Alive and Well in Healthcare

The backlash against global trade and the resurgence of protectionism is increasingly evident, mostly out of the U.S.
Read More →

South Korea takes steps to lower pharma prices

South Korea’s latest moves to make drugs more affordable are slowing down the growth of the pharma market in the country and maybe hurting sales ...
Read More →

China’s pivot to America could overshadow the US’s pivot to Asia

There has been so much discussion of the United States pivot to Asia that few people have stopped to consider the implications or the success ...
Read More →

A China-US trade war is not likely to be

All the talk that has erupted in the past couple of weeks about possible trade wars between the United States and China has been interesting ...
Read More →

Poverty, growth and baseless anger

Fast growing Asian countries have “eliminated” poverty at an astonishing speed, bringing people out of extreme poverty into mere gut-reaching poverty.
Read More →

Dealing with drugs: Colombia’s dilemma

There are few issues with just two sides or a clear right and wrong. This is a recurrent theme for us and one that Sergio ...
Read More →

A dengue vaccine… finally

It has been a long time coming, but the first dengue vaccine should hit the market next year in Mexico and, with any luck, in ...
Read More →

2016 BOAO Forum for Asia

This year’s BOAO Forum for Asia (BFA) has a theme of Asia’s New Future: New Dynamics, New Vision.
Read More →

R&D spend driving China pharma co’s

China is not a powerhouse of innovation, yet, but it is certainly trying to pay its way into that particular status.
Read More →

Australia’s largest life science fund

It is no surprise that the life science sector including pharmaceutical, medical devices etc. is one of the hottest investment destinations.
Read More →

Indonesia’s FDI troubles

When Indonesia’s Investment Coordinating Board (BKPM) rejected some 6,541 foreign investment permits last month, it underscored a problem Indonesia has been facing for a couple ...
Read More →

Asian cities need sustainability

Environment, productivity and work hours are all big issues
Read More →

Cheap oil helps Indonesia

Cheap oil has helped Indonesia eliminate punishing subsidies and while the move is likely to bump inflation up, it will also free up a about ...
Read More →

Bitcoin in Hong Kong

While many see Hong Kong as ideally positioned to become a global hub for digital currencies and internet finance, the road forward seems far from ...
Read More →

China Issues Biosimilar Guidelines Draft

After years of waiting, Chinese biosimilar makers will soon have a set of guidelines to follow.
Read More →

Venezuela’s farcical medical device crisis

The government of Venezuela, which owes medical device companies around the world more than US$245 million, is now calling for the arrest of domestic device ...
Read More →

HK protests impressive but status confusing

Eight days into the protests that have shut down entire neighbourhoods of the city, things are looking… ah… complicated.
Read More →

Vaccines are good

Vaccines are great. They are arguably one of the most important public health tools of the last century.
Read More →

Malaysian rate hike signals new trend

Malaysia’s central bank welcomed Ramadan fasts and celebrations through July and August by raising the country’s interest rate for the first time in three years.
Read More →

World Cup economics benefits are virtually nill

The World Cup is finished, much to the chagrin of our favorite Argentine team that came so close to taking a third cup only to ...
Read More →

Another burst in Japan: drug approvals

Japan’s healthcare industry has been marked by a fascinating dichotomy for the last couple of decades. A dichotomy that hurt patients most of all.
Read More →

Latin America: The Forgotten Continent

The chaotic Latin American market is key to publications in a wide range of areas and is one that those with a focus on Asia ...
Read More →

Chinese Investment Is Far From Scary

A new report suggests Chinese FDI in U.S. high tech may not be as scary as popular opinion there would have us believe.
Read More →

Healthcare Research Suggests More Growth in the Offing

Japan’s efforts to recreate its healthcare funding system provides at least one reason behind the ongoing bull market in healthcare and biotech.
Read More →

Volunteers Make Asian Miracles Possible

When major earthquakes all but destroyed Sumatra, in Indonesia, in 2004, a well-established tradition of volunteer labor made it possible for the region to recover.
Read More →